Chemoinformaics analysis of 3-Methyl-1-nitrobutane
| Molecular Weight | 117.148 | nRot | 3 |
| Heavy Atom Molecular Weight | 106.06 | nRig | 1 |
| Exact Molecular Weight | 117.079 | nRing | 0 |
| Solubility: LogS | -1.824 | nHRing | 0 |
| Solubility: LogP | 1.957 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 18.3887 |
| nHD | 0 | BPOL | 12.2013 |
| QED | 0.413 |
| Synth | 2.734 |
| Natural Product Likeliness | -0.072 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.003 |
| CACO-2 | -4.201 |
| MDCK | 0.000235261 |
| BBB | 0.965 |
| PPB | 0.611694 |
| VDSS | 0.807 |
| FU | 0.456951 |
| CYP1A2-inh | 0.783 |
| CYP1A2-sub | 0.411 |
| CYP2c19-inh | 0.382 |
| CYP2c19-sub | 0.8 |
| CYP2c9-inh | 0.083 |
| CYP2c9-sub | 0.731 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.503 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.181 |
| CL | 8.481 |
| T12 | 0.715 |
| hERG | 0.043 |
| Ames | 0.489 |
| ROA | 0.406 |
| SkinSen | 0.881 |
| Carcinogencity | 0.588 |
| EI | 0.987 |
| Respiratory | 0.843 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.954665 |